A detailed history of Cwm, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Cwm, LLC holds 545 shares of PRTA stock, worth $7,848. This represents 0.0% of its overall portfolio holdings.

Number of Shares
545
Previous 798 31.7%
Holding current value
$7,848
Previous $16,000 43.75%
% of portfolio
0.0%
Previous 0.0%

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024

SELL
$16.73 - $24.79 $4,232 - $6,271
-253 Reduced 31.7%
545 $9,000
Q2 2024

Jul 09, 2024

SELL
$19.54 - $26.15 $5,803 - $7,766
-297 Reduced 27.12%
798 $16,000
Q1 2024

Apr 05, 2024

BUY
$24.75 - $40.66 $19,404 - $31,877
784 Added 252.09%
1,095 $27,000
Q4 2023

Feb 01, 2024

BUY
$32.31 - $52.32 $8,529 - $13,812
264 Added 561.7%
311 $11,000
Q3 2023

Oct 11, 2023

BUY
$47.3 - $70.6 $614 - $917
13 Added 38.24%
47 $2,000
Q2 2023

Aug 03, 2023

SELL
$48.26 - $78.59 $96 - $157
-2 Reduced 5.56%
34 $2,000
Q1 2023

Apr 28, 2023

SELL
$46.97 - $58.27 $2,536 - $3,146
-54 Reduced 60.0%
36 $2,000
Q4 2022

Feb 01, 2023

BUY
$52.05 - $65.0 $3,018 - $3,770
58 Added 181.25%
90 $5,000
Q2 2022

Jul 28, 2022

SELL
$22.73 - $39.98 $227 - $399
-10 Reduced 23.81%
32 $1,000
Q1 2022

Apr 21, 2022

BUY
$30.27 - $49.22 $302 - $492
10 Added 31.25%
42 $2,000
Q1 2021

Sep 15, 2021

SELL
$11.0 - $28.24 $132 - $338
-12 Reduced 27.27%
32 $2,000
Q1 2021

Apr 27, 2021

BUY
$11.0 - $28.24 $132 - $338
12 Added 37.5%
44 $1,000
Q4 2020

Sep 15, 2021

SELL
$10.12 - $13.94 $121 - $167
-12 Reduced 27.27%
32 $2,000
Q4 2020

Jan 27, 2021

BUY
$10.12 - $13.94 $121 - $167
12 Added 37.5%
44 $1,000
Q3 2020

Sep 15, 2021

BUY
$9.93 - $13.47 $317 - $431
32 New
32 $2,000
Q3 2020

Oct 19, 2020

SELL
$9.93 - $13.47 $317 - $431
-32 Closed
0 $0
Q2 2020

Sep 15, 2021

BUY
$9.56 - $12.51 $305 - $400
32 New
32 $2,000
Q2 2020

Jul 22, 2020

SELL
$9.56 - $12.51 $305 - $400
-32 Closed
0 $0
Q1 2020

Sep 15, 2021

BUY
$7.54 - $15.77 $241 - $504
32 New
32 $2,000
Q1 2020

Apr 28, 2020

SELL
$7.54 - $15.77 $241 - $504
-32 Closed
0 $0
Q4 2019

Sep 14, 2021

BUY
$7.48 - $17.01 $239 - $544
32 New
32 $2,000
Q4 2019

Jan 27, 2020

SELL
$7.48 - $17.01 $239 - $544
-32 Closed
0 $0
Q3 2019

Sep 14, 2021

BUY
$6.89 - $10.45 $220 - $334
32 New
32 $2,000
Q3 2019

Oct 22, 2019

SELL
$6.89 - $10.45 $220 - $334
-32 Closed
0 $0
Q2 2019

Sep 14, 2021

BUY
$8.85 - $12.49 $283 - $399
32 New
32 $2,000
Q2 2019

Jul 31, 2019

SELL
$8.85 - $12.49 $283 - $399
-32 Closed
0 $0
Q1 2019

Sep 02, 2021

BUY
$10.32 - $14.49 $330 - $463
32 New
32 $0

Others Institutions Holding PRTA

About PROTHENA CORP PUBLIC LTD CO


  • Ticker PRTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,922,800
  • Market Cap $676M
  • Description
  • Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...
More about PRTA
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.